Ratnakar Securities Pvt. Ltd.

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC

BSE25462.20-282.1 (-1.1 %)

PREV CLOSE ( ) 25744.30

OPEN PRICE ( ) 25993.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 815

TODAY'S LOW / HIGH ( )25401.45 25993.75

52 WK LOW / HIGH ( )20594.25 29628.15

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1944

Management Info

Munir Shaikh - Chairman - Managing Director

Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022-50461000 / 2000 / 67978888

Email webmasterindia@abbott.com / investorrelations.india@abbott.com

Website www.abbott.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

12Apr Abbott India informs about appointment
In compliance with Regulation 30 of the Securities and Exchange Board of..

27Mar Abbott India informs about newspaper a
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

19Mar Abbott India informs about resignation
With reference to its earlier communication dated December 19, 2023, whe..

15Mar Abbott India informs about change in s
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..

13Mar Abbott India informs about change in d
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	3109.8	9494.1
Gross Profit	4221.6	12738.2
Operating Profit	4433	13597.8
Net Sales	14371.4	53487.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2621.00 (5.75%)	M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE) 2079.80 (7.06%)	M.Cap ( in Cr)35233.07
TTK Healthcare (BSE) 1591.35 (5.77%)	M.Cap ( in Cr)2248.63
Cipla (BSE) 1398.80 (3.79%)	M.Cap ( in Cr)112938.41
Torrent Pharma (BSE) 2685.00 (1.85%)	M.Cap ( in Cr)90872.60

Shareholding Pattern

	PROMOTERS	74.99%
	MUTUAL FUNDS/UTI	7.57%
	NON-INSTITUTION	15.92%
	FI/BANKS/INSURANCE	1.23%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Magnum Global F...	5.75
LIC MF Healthcare F...	4.51
WOC Pharma and Heal...	3.93
NJ ELSS Tax Saver S...	3.76
SBI Healthcare Opp ...	3.72
Nippon India Pharma...	3.29

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

ABBOTT INDIA LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES